Literature DB >> 2203764

Preferential DNA repair of alkali-labile sites within the active insulin gene.

S P LeDoux1, N J Patton, J W Nelson, W A Bohr, G L Wilson.   

Abstract

DNA damage and repair were studied in a DNA fragment containing the insulin gene after treatment of cells with methylnitrosourea. For these studies, two clonal isolates from the same rat insulinoma cell line which differ in that the insulin gene is transcribed in one (RINr 38) and is silent in the other (RINr B2) were utilized. Both the determination of immunologically reactive insulin released and the expression of insulin mRNA were used to verify that the gene was transcribed in the RINr 38 cells and not in the RINr B2 cells. Repair kinetics for the removal of alkali-labile sites were comparable across the entire genome in the RINr 38 and RINr B2 cells as determined using alkaline sucrose gradient sedimentation and a 32P end-labeling assay for the quantitation of N7-methylguanine. Quantitative DNA blot analysis was utilized to assess the formation and repair of alkali-labile sites within the restriction fragment containing the insulin gene. Alkali-labile sites appeared to be formed equally within the restriction fragment containing the insulin gene in both the RINr 38 and RINr B2 cells. However, at 24 h, 60% of the lesions were removed from the fragment in the RINr 38 cells, where the gene was transcribed, compared to the removal of only 20% in the RINr B2 cells, where the gene was silent. Thus, it appears that alkali-labile sites induced by exposure to methylnitrosourea are repaired more efficiently in the DNA fragment containing the insulin gene when it is actively transcribed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2203764

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Evolutionary consequences of nonrandom damage and repair of chromatin domains.

Authors:  T Boulikas
Journal:  J Mol Evol       Date:  1992-08       Impact factor: 2.395

2.  Analysis of DNA damage and repair in murine leukemia L1210 cells using a quantitative polymerase chain reaction assay.

Authors:  D P Kalinowski; S Illenye; B Van Houten
Journal:  Nucleic Acids Res       Date:  1992-07-11       Impact factor: 16.971

3.  Processing in vitro of an abasic site reacted with methoxyamine: a new assay for the detection of abasic sites formed in vivo.

Authors:  S Rosa; P Fortini; P Karran; M Bignami; E Dogliotti
Journal:  Nucleic Acids Res       Date:  1991-10-25       Impact factor: 16.971

4.  Functional nucleotide excision repair is required for the preferential removal of N-ethylpurines from the transcribed strand of the dihydrofolate reductase gene of Chinese hamster ovary cells.

Authors:  A Sitaram; G Plitas; W Wang; D A Scicchitano
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

5.  Monoclonal antibody-based, selective isolation of DNA fragments containing an alkylated base to be quantified in defined gene sequences.

Authors:  K Hochleitner; J Thomale; M F Rajewsky
Journal:  Nucleic Acids Res       Date:  1991-08-25       Impact factor: 16.971

6.  Strand-specificity in the transformation of yeast with synthetic oligonucleotides.

Authors:  T Yamamoto; R P Moerschell; L P Wakem; S Komar-Panicucci; F Sherman
Journal:  Genetics       Date:  1992-08       Impact factor: 4.562

7.  Mammalian assay for site-specific DNA damage processing using the human H-ras proto-oncogene.

Authors:  L Arcangeli; K J Williams
Journal:  Nucleic Acids Res       Date:  1995-06-25       Impact factor: 16.971

8.  Intragenomic repair heterogeneity of DNA damage.

Authors:  D A Scicchitano; P C Hanawalt
Journal:  Environ Health Perspect       Date:  1992-11       Impact factor: 9.031

9.  Oxidative stress-induced apoptosis in neurons correlates with mitochondrial DNA base excision repair pathway imbalance.

Authors:  Jason F Harrison; Scott B Hollensworth; Douglas R Spitz; William C Copeland; Glenn L Wilson; Susan P LeDoux
Journal:  Nucleic Acids Res       Date:  2005-08-17       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.